Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Heska has become the sole provider of point-of-care diagnostics and consumables to Ethos Veterinary Health.
Singapore-based Credo Biomedical is seeking global partners to take its point-of-care (POC) molecular diagnostics for companion animals to a wider sales base.
Zoetis has signed a license and commercialization agreement with Advanced Animal Diagnostics (AAD) for mastitis detection technology.
PBD Biotech has boosted its intellectual property after a patent covering its Actiphage technology was granted by the European Patent Office.
Johne's disease can be now more easily detected in the blood of day-old calves, according to new studies from UK firm PBD Biotech.
Zoetis has evaluated the progress of its African Livestock Productivity and Health Advancement (A.L.P.H.A.) initiative during the project's second year.
Two new studies have established that phytase offers tilapia producers a threefold benefit, claims AB Vista.
Canadian company Biovet has introduced a new duplex assay to its portfolio of swine products.
The UK's Pirbright Institute has developed a novel foot-and-mouth disease (FMD) reagent that has the potential to be used in diagnostics tests and reduce the need for animals in testing.
Washington State University's (WSU) College of Veterinary Medicine (CVM) has broken ground on a new facility for the Washington Animal Disease Diagnostic Laboratory (WADDL).
This year saw the 10th annual Kansas City Animal Health Investment Forum host a wide array of companies yearning to innovate and disrupt the animal health market. Animal Pharm analyst Daniel Willis gives an overview of the start-ups on display.
Heska has participated in the $6 million series B financing round of MBio Diagnostics.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.